Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has received a suspension order for its drug license concerning a store located in Kolhapur, Maharashtra. The suspension, lasting ten days, was issued by the Assistant Director of the Food & Drugs Control Administration, with the order dated December 24, 2024. The company estimates a potential revenue loss of approximately ₹2.3 lakh (~Cr 0.023). This development could impact MedPlus's operational capabilities and warrants close monitoring for any further repercussions on overall business performance.